{"id":16428,"date":"2022-12-15T14:17:17","date_gmt":"2022-12-15T13:17:17","guid":{"rendered":"https:\/\/convergences.online\/hemato\/?p=16428"},"modified":"2022-12-15T14:17:17","modified_gmt":"2022-12-15T13:17:17","slug":"darzalexdaratumumab-recompense-pour-la-seconde-fois-de-son-histoire-par-le-tres-prestigieux-prix-galien-france-dans-le-volet-medicaments-reserves-en-therapeutique-hospitaliere-dans-le-traite","status":"publish","type":"post","link":"https:\/\/www.hematostat.net\/en\/darzalexdaratumumab-recompense-pour-la-seconde-fois-de-son-histoire-par-le-tres-prestigieux-prix-galien-france-dans-le-volet-medicaments-reserves-en-therapeutique-hospitaliere-dans-le-traite\/","title":{"rendered":"Darzalex\u00ae(daratumumab) r\u00e9compens\u00e9 pour la seconde fois de son histoire par le tr\u00e8s prestigieux Prix Galien France, dans le volet m\u00e9dicaments r\u00e9serv\u00e9s en th\u00e9rapeutique hospitali\u00e8re, dans le traitement, d\u00e8s la 1\u00e8re ligne, des patients atteints de my\u00e9lome multiple et d\u2019amylose syst\u00e9mique \u00e0 cha\u00eenes l\u00e9g\u00e8res (AL)."},"content":{"rendered":"<p>L\u2019annonce a \u00e9t\u00e9 faite \u00e0 l\u2019occasion de la c\u00e9r\u00e9monie du Prix Galien France qui s\u2019est tenue le 15 d\u00e9cembre 2022 \u00e0 Paris. Le daratumumab repr\u00e9sente une avanc\u00e9e importante dans le traitement d\u00e8s la 1<sup>\u00e8re<\/sup> ligne, du my\u00e9lome multiple, et de l\u2019amylose syst\u00e9mique \u00e0 cha\u00eenes l\u00e9g\u00e8res (AL).<\/p>\n<p>Un 8<sup>\u00e8me<\/sup> Prix Galien d\u00e9cern\u00e9 \u00e0 Janssen France et le 2<sup>\u00e8me<\/sup> pour Darzalex\u00ae. C&#8217;est la premi\u00e8re fois, qu\u2019une innovation th\u00e9rapeutique obtient deux fois ce prix.<\/p>\n<p>Ce prix vient reconna\u00eetre la place centrale de Darzalex\u00ae (daratumumab) dans la prise en charge du my\u00e9lome multiple et de l\u2019amylose AL avec quatre extensions d\u2019indications :<\/p>\n<p>&#8211; trois dans la prise en charge du my\u00e9lome multiple nouvellement diagnostiqu\u00e9 ;<\/p>\n<p>&#8211; une dans la prise en charge de l\u2019amylose AL nouvellement diagnostiqu\u00e9e.<\/p>\n<p>L\u2019aventure Darzalex\u00ae (daratumumab) n\u2019est pas termin\u00e9e puisqu\u2019il fait encore l\u2019objet d\u2019un programme de d\u00e9veloppement dans lequel la France est particuli\u00e8rement impliqu\u00e9e.<\/p>\n<p>&nbsp;<\/p>\n<p><em>D&#8217;apr\u00e8s un communiqu\u00e9 de presse de Janssen, 15 d\u00e9cembre 2022.<\/em><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>L\u2019annonce a \u00e9t\u00e9 faite \u00e0 l\u2019occasion de la c\u00e9r\u00e9monie du Prix Galien France qui s\u2019est tenue le 15 d\u00e9cembre 2022 \u00e0 Paris. Le daratumumab repr\u00e9sente une avanc\u00e9e importante dans le [&hellip;]<\/p>","protected":false},"author":17,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[21],"tags":[],"ppma_author":[457],"class_list":["post-16428","post","type-post","status-publish","format-standard","hentry","category-communique-de-presse","author-pascale-raoul"],"aioseo_notices":[],"authors":[{"term_id":457,"user_id":17,"is_guest":0,"slug":"pascale-raoul","display_name":"Pascale Raoul","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","first_name":"","last_name":"","user_url":"","description":""}],"_links":{"self":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts\/16428","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/comments?post=16428"}],"version-history":[{"count":0,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts\/16428\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/media?parent=16428"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/categories?post=16428"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/tags?post=16428"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/ppma_author?post=16428"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}